Ludwig Norbert Michel Hantson (born August 1962) is a Belgium businessman, the CEO of Alexion Pharmaceuticals since March 2017. He was the president and CEO of

Baxalta Baxalta (''Bax'' from the name of its former parent company; ''alta'' a Latin adjective meaning 'high' or 'profound') is a biopharmaceutical company founded on 1 July 2015 after its parent company, Baxter International, spun off biopharmaceutica ...

, an American biopharmaceutical company, from 2015 to 2016.

Early life

Hantson received a PhD in Motor Rehabilitation and Physical Therapy from the

University of Louvain A university () is an institution of higher (or tertiary) education and research which awards academic degrees in several academic disciplines. Universities typically offer both undergraduate and postgraduate programs. In the United States, the ...

in Belgium.

Career

Hantson was corporate vice president and president, international of Baxter from May 2010, before becoming CEO of Baxalta from July 2015, when Baxalta was spun off by its parent company,

Baxter International Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat kidney disease, and other chronic and acute medical conditions. The company ...

until the finalization of Baxalta's acquisition a year later (completed June 2016) by

Shire Shire is a traditional term for an administrative division of land in Great Britain and some other English-speaking countries such as Australia and New Zealand. It is generally synonymous with county. It was first used in Wessex from the beginn ...

. It was reported in January 2016 that Hantson's exit package, in cash and Shire stock, could be more than $30 million. In March 2017, Alexion Pharmaceuticals named Hantson as its CEO. In September 2017, Hantson relocated Alexion Pharmaceuticals's headquarters to Massachusetts.

References

{{DEFAULTSORT:Hantson, Ludwig N 1962 births Living people Belgian businesspeople Belgian chief executives